Bank of New York Mellon »

Zentalis Pharmaceuticals shares owned by Bank of New York Mellon

Quarter-by-quarter ownership of Zentalis Pharmaceuticals (ZNTL) shares owned by Bank of New York Mellon from 13F filings

Historical chart of Bank of New York Mellon investment in Zentalis Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Zentalis Pharmaceuticals held by Bank of New York Mellon consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Zentalis Pharmaceuticals by Bank of New York Mellon

Quarter filed Position value Share count Share price at filing
2024-09-30 $638k 173k 3.68
2024-06-30 $1.4M 334k 4.09
2024-03-31 $4.6M 290k 15.76
2023-12-31 $4.4M 290k 15.15
2023-09-30 $4.9M 242k 20.06
2023-06-30 $4.6M 165k 28.21
2023-03-31 $2.7M 156k 17.20
2022-12-31 $3.2M 158k 20.14
2022-09-30 $3.3M 153k 21.66
2022-06-30 $3.3M 118k 28.08
2022-03-31 $6.6M 144k 46.14
2021-12-31 $12M 144k 85.47
2021-09-30 $9.2M 139k 66.64
2021-06-30 $5.0M 95k 53.19
2021-03-31 $3.9M 90k 43.40
2020-12-31 $5.0M 97k 51.93
2020-09-30 $1.1M 33k 32.74
2020-06-30 $0 31k 0.00